Matches in Wikidata for { <http://www.wikidata.org/entity/Q63811703> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q63811703 description "clinical trial" @default.
- Q63811703 description "ensayu clínicu" @default.
- Q63811703 description "klinisch onderzoek" @default.
- Q63811703 description "клінічне випробування" @default.
- Q63811703 description "կլինիկական փորձարկում" @default.
- Q63811703 name "A Long Term Study to Demonstrate the Safety and Efficacy of Tildrakizumab in Subjects With Psoriatic Arthritis and Ankylosing Spondylitis or Non-Radiographic Axial Spondyloarthritis." @default.
- Q63811703 type Item @default.
- Q63811703 label "A Long Term Study to Demonstrate the Safety and Efficacy of Tildrakizumab in Subjects With Psoriatic Arthritis and Ankylosing Spondylitis or Non-Radiographic Axial Spondyloarthritis." @default.
- Q63811703 prefLabel "A Long Term Study to Demonstrate the Safety and Efficacy of Tildrakizumab in Subjects With Psoriatic Arthritis and Ankylosing Spondylitis or Non-Radiographic Axial Spondyloarthritis." @default.
- Q63811703 P1050 Q63811703-6725B9AD-2DEA-4F50-9134-A63256D1103E @default.
- Q63811703 P1050 Q63811703-E0A7F00B-D1C8-46C6-A067-CEF1F843EC60 @default.
- Q63811703 P1132 Q63811703-D6127D5F-42A6-42DE-8334-1D8619E112D7 @default.
- Q63811703 P1476 Q63811703-987EFA95-E90B-4C10-B5B9-0732B23EE670 @default.
- Q63811703 P17 Q63811703-065DA7A2-CD4B-4C24-B2CE-3A0128EF387C @default.
- Q63811703 P17 Q63811703-1120EB94-CA93-4510-BC1E-F80B65955835 @default.
- Q63811703 P17 Q63811703-461E5B3F-C038-41D4-87B2-BA3A386FC1B7 @default.
- Q63811703 P17 Q63811703-5942E0B7-1392-4CA9-8ACE-42C4F8DB1E5D @default.
- Q63811703 P17 Q63811703-6FF93769-FB3C-4B2B-8CC4-68E3119936BF @default.
- Q63811703 P17 Q63811703-96D2ADC0-5F29-47F7-AD51-7F907AABC257 @default.
- Q63811703 P17 Q63811703-D6AB7442-1621-4155-859F-B7D9F0433769 @default.
- Q63811703 P2899 Q63811703-7936E6D0-EE57-4C4C-9B00-1E05544EA67D @default.
- Q63811703 P3098 Q63811703-3CFED4BD-EFB5-4AE5-9579-6380A804A067 @default.
- Q63811703 P31 Q63811703-6B1B4BDE-5A82-43FE-A0E6-68551CDEA680 @default.
- Q63811703 P580 Q63811703-10B4B839-A495-4EAF-A3EE-3E90DEEC6214 @default.
- Q63811703 P582 Q63811703-B51AB8C4-59D0-44BA-859F-5F1CA8983681 @default.
- Q63811703 P6099 Q63811703-8F91D127-A4CB-4CB8-94F7-CD990C99A0AA @default.
- Q63811703 P6099 Q63811703-F687A434-C5C6-420F-9EBC-BEF3B001E3A6 @default.
- Q63811703 P8363 Q63811703-C575A119-8103-474C-A2AB-363B126A04D4 @default.
- Q63811703 P1050 Q170990 @default.
- Q63811703 P1050 Q2165411 @default.
- Q63811703 P1132 "+540" @default.
- Q63811703 P1476 "A Multiple-Dose, Long-Term Extension Study to Demonstrate the Safety and Efficacy of Tildrakizumab in Subjects With Psoriatic Arthritis and Ankylosing Spondylitis or Non-Radiographic Axial Spondyloarthritis Who Have Previously Completed Studies With Tildrakizumab." @default.
- Q63811703 P17 Q212 @default.
- Q63811703 P17 Q28 @default.
- Q63811703 P17 Q29 @default.
- Q63811703 P17 Q30 @default.
- Q63811703 P17 Q36 @default.
- Q63811703 P17 Q414 @default.
- Q63811703 P17 Q96 @default.
- Q63811703 P2899 "+18" @default.
- Q63811703 P3098 "NCT03552276" @default.
- Q63811703 P31 Q30612 @default.
- Q63811703 P580 "2018-07-11T00:00:00Z" @default.
- Q63811703 P582 "2023-06-30T00:00:00Z" @default.
- Q63811703 P6099 Q42824440 @default.
- Q63811703 P6099 Q42824827 @default.
- Q63811703 P8363 Q78089383 @default.